Lb Pharmaceuticals
(NASDAQ) LBRX
Lb Pharmaceuticals Financials at a Glance
Market Cap
$595.29M
Revenue (TTM)
$0.00
Net Income (TTM)
$27.91M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
0.76 (Low)
Dividend
$0.00
Beta (Volatility)
0.76 (Low)
Price
$23.51
Volume
38,995
Open
$23.80
Price
$23.51
Volume
38,995
Open
$23.80
Previous Close
$23.51
Daily Range
$23.40 - $24.38
52-Week Range
$13.36 - $27.55
Dividend
$0.00
Beta (Volatility)
0.76 (Low)
Price
$23.51
Volume
38,995
Open
$23.80
Previous Close
$23.51
Daily Range
$23.40 - $24.38
52-Week Range
$13.36 - $27.55
LBRX News
LBRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lb Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareCEO
Heather D. Turner
Website
www.lbpharma.usHeadquarters
New York, NY 10119, US
LBRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-10%
Return on Assets
-9%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$595.29M
Shares Outstanding
25.30M
Volume
38.99K
Short Interest
0.00%
Avg. Volume
242.58K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$64.83M
EBITDA
$63.01M
Operating Cash Flow
$53.05M
Capital Expenditure
$769.00K
Free Cash Flow
$53.82M
Cash & ST Invst.
$28.00M
Total Debt
$3.70M
Lb Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$81.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$595.29M
N/A
Market Cap/Employee
$37.21M
N/A
Employees
16
N/A
Net Income
$3.56M
+87.2%
EBITDA
$3.48M
+87.2%
Quarterly Fundamentals
Net Cash
$310.81M
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$2.94M
N/A
Short Term Debt
$730.00K
N/A
Return on Assets
-8.70%
N/A
Return on Invested Capital
-10.38%
N/A
Free Cash Flow
$3.37M
+78.7%
Operating Cash Flow
$3.37M
+78.6%